Drug
Sapropterin
Sapropterin: highest development phase Phase 2/3, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| sapropterin NCT00935753 | Phase 2/3 | Behavioral Manifestations of Lesch-Nyhan Disease |
Latest
No recent events.
Follow Sapropterin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.